Given the regulatory relationship between NCAPG2 and c-MYC, and aberrant c-MYC overexpression has been linked to cancer cell stemness [37–39], we further explored the potential role of NCAPG2 in PCa-CSCs. This evidence concerns the gene MYC and cancer.